May 2nd 2024
This study monitored viral load in asymptomatic blood donors, unveiling insights into the progression of HEV infections, vital for public health strategies.
HBV Infection Linked to Threefold Increase in Fibrosis in Patients with Liver Disease
February 17th 2023A recent study suggests that metabolic factors such as hypertension and diabetes were associated with an increased risk of liver fibrosis among patients with metabolic associated fatty liver disease who had hepatitis B virus infection.
Read More
FDA Expands Use of Vemlidy to Adolescents with Chronic HBV Infection
December 5th 2022Children as young as 12 can now receive tenofovir alafenamide for treatment of chronic hepatitis B virus infection with compensated liver disease, after the US Food and Drug Administration expanded the indication for the drug.
Read More